# Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis

> **NCT02718677** · — · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** Refacto AF

## Key facts

- **NCT ID:** NCT02718677
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-09-01
- **Primary completion:** 2021-05-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Company decision to not conduct study
- **Last updated:** 2020-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02718677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02718677, "Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02718677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*